Rethink Medical — T-Control®
OverviewHow it worksInstructions for useTraining
The clinical problemHealthcare professionalsPatients
Evidence
About usTeamSocial responsibility
News
en|es
Contact
en|es

Professional area

Designed by nurses, for clinical reality.

T-Control® is an indwelling urinary catheter with an integrated flow-control valve designed to support controlled urinary drainage and simplify catheter management.

Information intended for healthcare professionals

Value proposition

Four design characteristics of T-Control®

Integrated flow control

The integrated valve allows urinary flow to be opened and closed directly from the catheter.

Controlled drainage

Allows controlled bladder filling and emptying instead of continuous free drainage when clinically appropriate.

Drainage bag compatibility

T-Control® can be connected to a urinary drainage bag for continuous drainage when clinically indicated.

Clinical handling

The flow-control mechanism is integrated into the catheter. Insertion and removal must be performed by healthcare professionals in accordance with the Instructions for Use and the aseptic technique established by the healthcare facility.

Technique & training

Official training video, Best Practices Programme and simulation-based learning developed with nursing teams and universities.

Training resources

Scientific evidence

Peer-reviewed publications, congress abstracts and clinical studies carried out with hospitals and academic partners.

Browse the evidence

Perspective

What professionals say

Healthcare professionals share their experience with conventional urinary catheterisation and the practical challenges that may arise in day-to-day life with some of the alternatives used by patients, such as catheter plugs.

Selecting play loads the video from YouTube in privacy-enhanced mode (youtube-nocookie.com). YouTube may then store information on your device.

Evaluate T-Control® in your unit

We work with hospitals and care centres to plan product evaluations, training and implementation support.

Talk to our clinical team

Healthcare Professionals Only

This section contains information intended for healthcare professionals. Please confirm whether you are a healthcare professional.

Rethink Medical — T-Control®

Medical device company rethinking urinary catheterisation through clinician-led innovation.

  • Calle Practicante Ignacio Rodríguez S/N, Edificio Polivalente II del Campus Universitario de Tafira
    35017 Las Palmas de Gran Canaria, España
  • info@rethinkmedical.es
Follow us on LinkedIn

T-Control®

  • Overview
  • How it works
  • Instructions for use
  • Training

Why it matters

  • The clinical problem
  • Healthcare professionals
  • Patients
  • Evidence

Company

  • About us
  • Team
  • Social responsibility
  • News
  • Contact

Transparency & legal

  • Quality policy
  • Public funding
  • Transparency portal
  • Legal notice
  • Privacy policy
  • Cookie Policy

Public funding & institutional support

CDTI · Plan de Recuperación, Transformación y Resiliencia · Next Generation EUSODECAN · Canarias Financia · FEDER · Gobierno de CanariasPrograma Investigo · Servicio Canario de EmpleoENISA

The following disclosures reproduce, as required by the funding bodies, the official titles of publicly funded R&D projects. These titles describe research objectives and do not constitute claims regarding the intended purpose or clinical performance of any CE-marked device.

Este proyecto ha recibido financiación del CDTI a través del Programa de Ayudas a PYMEs con Sello de Excelencia del Acelerador del EIC de Horizonte Europa.

RETHINK MEDICAL S.L. ha recibido un préstamo ordinario de Línea Financiera para la innovación empresarial para PYMES, del Fondo Canarias Financia 1, para la financiación del proyecto denominado “CATÉTER URINARIO INNOVADOR DESTINADO A REDUCIR LAS INFECCIONES, AUMENTAR LA CALIDAD DE VIDA DE LOS PACIENTES Y MEJORAR LA EFICIENCIA DEL TRABAJO EN EL HOSPITAL”, cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) en un 85% a través del Programa Operativo FEDER de Canarias 2014-2020, contribuyendo al cumplimiento de los objetivos del eje prioritario 1 "Potenciar la investigación, el desarrollo tecnológico y la innovación", Objetivo Específico 1.2.1 "Impulso y promoción de actividades de I+i lideradas por las empresas, apoyo a la creación y consolidación de empresas innovadoras y apoyo a la compra pública innovadora.”

© 2026 Rethink Medical S.L. · CIF B76209824. All rights reserved.

T-Control® — Medical Device, Class IIb, Regulation (EU) 2017/745, CE 0123. Read the instructions for use before handling. Availability is subject to local regulatory requirements. T-Control® is not cleared for sale in the United States.